Otsuka Holdings Co., Ltd. (OTSKF)

Market Cap	36.45B +38.5%
Revenue (ttm)	15.75B +6.0%
Net Income	2.32B +5.8%
EPS	4.37 +8.1%
Shares Out	n/a
PE Ratio	15.74
Forward PE	n/a
Dividend	0.93 (1.34%)
Ex-Dividend Date	Dec 29, 2025

Volume	212
Average Volume	1,120
Open	69.59
Previous Close	70.34
Day's Range	69.59 - 69.59
52-Week Range	44.40 - 70.34
Beta	-0.08
RSI	66.63
Earnings Date	Apr 28, 2026

About Otsuka Holdings

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1921
• Employees: 37,758
• Stock Exchange: OTCMKTS
• Ticker Symbol: OTSKF

Financial Performance

In 2025, Otsuka Holdings's revenue was 2.47 trillion, an increase of 5.97% compared to the previous year's 2.33 trillion. Earnings were 363.15 billion, an increase of 5.84%.

Financial numbers in JPY